Aridis Pharmaceuticals, Inc. (ARDS)
OTCMKTS · Delayed Price · Currency is USD
0.0015
-0.0012 (-44.23%)
At close: Oct 23, 2025
Aridis Pharmaceuticals Market Cap
Aridis Pharmaceuticals has a market cap or net worth of $77.32 thousand as of October 24, 2025. Its market cap has decreased by -97.63% in one year.
Market Cap
77.32K
Enterprise Value
n/a
Revenue
22.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 14, 2018, Aridis Pharmaceuticals's market cap has decreased from 102.57M to 77.32K, a decrease of -99.92%. That is a compound annual growth rate of -63.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 77.32K | 1,350.02% |
| Dec 31, 2024 | 5.33K | -99.83% |
| Dec 29, 2023 | 3.18M | -89.17% |
| Dec 30, 2022 | 29.39M | -10.24% |
| Dec 31, 2021 | 32.75M | -46.41% |
| Dec 31, 2020 | 61.10M | 54.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 649.45M |
| Glass House Brands | 618.32M |
| Silence Therapeutics | 342.45M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 319.35M |
| Northwest Biotherapeutics | 305.00M |
| American Oncology Network | 297.14M |